UBE2D2B - C-terminal region Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-UBE2D2B - C-terminal region antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | UBE2D2B - C-terminal region |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | mouse |
| Isotype | n/a |
| Format | affinity purified |
| Size | 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Catalyzes the covalent attachment of ubiquitin to other proteins. Mediates the selective degradation of short-lived and abnormal proteins. Functions in the E6/E6-AP-induced ubiquitination of p53/TP53. Mediates ubiquitination of PEX5 and autoubiquitination of STUB1 and TRAF6. Involved in the signal-induced conjugation and subsequent degradation of NFKBIA, FBXW2-mediated GCM1 ubiquitination and degradation, MDM2-dependent degradation of p53/TP53 and the activation of MAVS in the mitochondria by DDX58/RIG-I in response to viral infection (By similarity). Plays a role in early maturation of the testis. |
| Immunogen | Immunogen: The immunogen is a synthetic peptide directed towards the C terminal region of mouse UBE2D2B |
| Other Names | [ubiquitin-conjugating enzyme E2 D2B; Ubiquitin-conjugating enzyme E2 D2B; ubiquitin-conjugating enzyme E2 D2B; ubiquitin-conjugating enzyme E2D 2B; E2 ubiquitin-conjugating enzyme D2B; Ubiquitin carrier protein D2B; Ubiquitin-protein ligase D2B] |
| Gene, Accession # | [UBE2D2B], Gene ID: 73318, NCBI: NP_001263326.1, UniProt: Q6ZWY6 |
| Catalog # | MBS3224048 |
| Price | $335 |
| Order / More Info | UBE2D2B - C-terminal region Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies